Analyst Ims Investment Management Services Ltd. Teva Pharmaceutical Industries LTD Transaction History

Analyst Ims Investment Management Services Ltd.

$2.6 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $128,114 - $209,339	-8,781 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $184,927 - $225,232	8,781 New	8,781 $188,000
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $139,475 - $291,170	-9,051 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	9,051	9,051 $300,000

Others Institutions Holding TEVA

# of Institutions

640

Shares Held

580M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$740 Million
0.02% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

39M
Shares

$671 Million
7.75% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$624 Million
35.87% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$496 Million
3.32% of portfolio
Exor Capital LLP London, X0

27.2M
Shares

$468 Million
17.5% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Analyst Ims Investment Management Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Analyst Ims Investment Management Services Ltd. with notifications on news.

Account